Evidence map›Paper›PMID 35609439›Full record

ArticlePLoS biology2022

Transcriptome-wide mapping reveals a diverse dihydrouridine landscape including mRNA.

Austin S Draycott, Cassandra Schaening-Burgos, Maria F Rojas-Duran, Loren Wilson, Leonard Schärfen, Karla M Neugebauer, Sigrid Nachtergaele, Wendy V Gilbert

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Cytidine Acetylation Across the Tree of Life.Accounts of chemical research · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Austin S DraycottYale School of Medicine, Department of Molecular Biophysics & Biochemistry, New Haven, Connecticut, United States of America.ORCID 0000-0001-6002-1725
Cassandra Schaening-BurgosMassachusetts Institute of Technology, Department of Biology, Cambridge, Massachusetts, United States of America.ORCID 0000-0003-4793-5033
Maria F Rojas-DuranYale School of Medicine, Department of Molecular Biophysics & Biochemistry, New Haven, Connecticut, United States of America.
Loren WilsonYale University, Department of Molecular, Cellular, and Developmental Biology, New Haven, Connecticut, United States of America.
Leonard SchärfenYale School of Medicine, Department of Molecular Biophysics & Biochemistry, New Haven, Connecticut, United States of America.ORCID 0000-0003-0234-7609
Karla M NeugebauerYale School of Medicine, Department of Molecular Biophysics & Biochemistry, New Haven, Connecticut, United States of America.ORCID 0000-0002-3835-6761
Sigrid NachtergaeleYale University, Department of Molecular, Cellular, and Developmental Biology, New Haven, Connecticut, United States of America.
Wendy V GilbertYale School of Medicine, Department of Molecular Biophysics & Biochemistry, New Haven, Connecticut, United States of America.ORCID 0000-0003-2807-9657
Yale University · USMassachusetts Institute of Technology · US

Funding

Cross-regulation between transcription and pre-mRNA splicingR01GM112766 · NIGMS · YALE UNIVERSITY · PI Karla M Neugebauer · 2015 to 2026
$5.3M
Graduate Training in Computational and Systems BiologyT32GM087237 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BURGE, CHRISTOPHER B · 2009 to 2023
$4.6M
Functional alterations of the dihydrouridine landscape in response to environmental stressR21ES031525 · NIEHS · YALE UNIVERSITY · PI GILBERT, WENDY VICTORIA · 2020 to 2021
$494k
Cancer-associated alterations of the dihydrouridine landscape in kidney cancerR21CA246118 · NCI · YALE UNIVERSITY · PI GILBERT, WENDY VICTORIA · 2020 to 2021
$422k
Developing Tools to Map and Quantify Dihydrouridine in the Mammalian TranscriptomeF31CA254339 · NCI · YALE UNIVERSITY · PI DRAYCOTT, AUSTIN STRATTON · 2020 to 2022
$138k
NCI NIH HHS F31 CA254339NCI NIH HHS R21 CA246118NIEHS NIH HHS R21 ES031525NIGMS NIH HHS R01 GM112766NIGMS NIH HHS T32 GM087237
6 · The paper itself

Abstract

Dihydrouridine is a modified nucleotide universally present in tRNAs, but the complete dihydrouridine landscape is unknown in any organism. We introduce dihydrouridine sequencing (D-seq) for transcriptome-wide mapping of D with single-nucleotide resolution and use it to uncover novel classes of dihydrouridine-containing RNA in yeast which include mRNA and small nucleolar RNA (snoRNA). The novel D sites are concentrated in conserved stem-loop regions consistent with a role for D in folding many functional RNA structures. We demonstrate dihydrouridine synthase (DUS)-dependent changes in splicing of a D-containing pre-mRNA in cells and show that D-modified mRNAs can be efficiently translated by eukaryotic ribosomes in vitro. This work establishes D as a new functional component of the mRNA epitranscriptome and paves the way for identifying the RNA targets of multiple DUS enzymes that are dysregulated in human disease.

Indexed as

RNATranscriptomeHumansNucleotidesRNA, MessengerSaccharomyces cerevisiaeNucleotidesRNARNA, Messenger

Identifiers

PMID35609439
PMCPMC9129914
OpenAlexW4282918487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.